RENAISSANCE TECHNOLOGIES LLC
Position in HRMY — Harmony Biosciences Holdings, Inc.
CIK 1037389
NEW YORK, NY
Position in HRMY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$43,523,458
+$13,346,297 QoQ
Shares Held
1,195,371
+11.0% QoQ
Ownership
2.05%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#12
of 328 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HRMY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,593,796 across 312 Biotechnology names. HRMY ranks #16 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in HRMY
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $43,523,458 | 1,195,371 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $30,177,161 | 1,077,371 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $40,057,024 | 1,070,471 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $31,337,676 | 1,137,071 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $29,371,283 | 929,471 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $27,891,913 | 840,371 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $19,567,969 | 568,671 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $19,704,000 | 492,600 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $17,975,286 | 595,800 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $12,763,758 | 380,100 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $8,349,550 | 258,500 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $9,572,117 | 292,100 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $14,441,976 | 410,400 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $15,208,370 | 465,800 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $18,882,770 | 342,700 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $14,394,250 | 325,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $14,231,086 | 291,800 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $6,932,625 | 142,500 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,747,872 | 134,800 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,510,202 | 39,400 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $333,114 | 11,800 | Shares | Sole | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||